The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
120 jobs Number of planned job creations
Announcement Date
26 February 2016
Employment effect (start)
Foreseen end date
Description
Swedish-Swiss pharmaceutical company Octapharma is to hire 120 new employees following renewed production permits from the country administrative board permitting larger production volumes at Octapharma's factory in Kungsholmen, Stockholm. Octapharma produces protein based pharmaceuticals from plasma. Currently Octapharma has the capacity to produce 1,500 (metric) tonnes of protein based pharmaceuticals yearly, following the renewed permit Octapharma will have the capacity to produce 3,500 tonnes, with plans to produce 2,700 tonnes of pharmaceuticals yearly before the end of 2017.
Beyond hiring new staff Octapharma with improve its production capacity through modernisation and reconstruction of its factory. Octapharma has an investment scheme for its factory in Stockholm amounting to a total of €39 million during 2016.
Sources
26 February 2016: Kemivärlden Biotech
Citation
Eurofound (2016), Octapharma, Business expansion in Sweden, factsheet number 86636, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/86636.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...